argenx to Present New Data from Generalized Myasthenia Gravis Program at 2022 American Academy of Neurology Annual Meeting
BREDA, the Netherlands--(BUSINESS WIRE)-- Regulatory Information: argenx SE (Euronext & Nasdaq: ARGX), a world immunology firm dedicated to enhancing the ...
